Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Biogen loses another pipeline drug to toxicity concerns

Follows discontinuation of Eisai-partnered Alzheimer's drug

- PMLiVE

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications

by Marc Valdiviezo

- PMLiVE

Purdue Pharma files for bankruptcy after opioid settlement

Company has faced brunt of blame for fuelling epidemic

People with blue dots

Can you survive without the blue dot?

Or has the digital world has replaced our brain

Page & Page Health

- PMLiVE

Novartis eyes potential new indication for Cosentyx

Unveils positive late-stage results in axial spondyloarthritis

- PMLiVE

Acceleron scraps rare muscular dystrophy drug

Clinical profile not strong enough to push into late-stage testing

- PMLiVE

J&J’s Tremfya filed for approval in US for psoriatic arthritis

Seeking share of increasingly competitive psoriasis market

- PMLiVE

New data backs GeNeuro’s MS drug after Servier exit

Search continues for new development partner

- PMLiVE

A roadmap to the successful treatment of Alzheimer’s disease

Building on past research to learn more about the disease and how to treat it

- PMLiVE

Envision Pharma Group relocates to support expansion

Office moves in the US prompted by significant growth

- PMLiVE

Trust: the ultimate elevator

By Andreas Reinbolz, Daniel Schäfer and Ralf Steinmetz

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links